Pulse Biosciences (PLSE) Non-Current Deffered Revenue (2017 - 2018)

Pulse Biosciences (PLSE) recorded quarterly Non-Current Deffered Revenue of $1.2 million in Q4 2018, down 8.13% quarter-over-quarter from $1.3 million in Q3 2018, and down 25.73% on a YoY basis from $1.6 million in Q4 2017.

Pulse Biosciences (PLSE) Non-Current Deffered Revenue (2017 - 2018) Analysis & Trends

Pulse Biosciences' Non-Current Deffered Revenue history runs 2 years deep, the most recent figure standing at $1.2 million for Q4 2018.

  • In Q4 2018, Non-Current Deffered Revenue fell 25.73% year-over-year to $1.2 million; the TTM figure through Dec 2018 stood at $1.2 million (down 25.73% YoY), while the FY2018 annual figure was $1.2 million, down 25.73% from the prior year.
  • Non-Current Deffered Revenue was $1.2 million for Q4 2018 at Pulse Biosciences, down from $1.3 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $1.8 million in Q2 2017 to a low of $1.2 million in Q4 2018.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Intuitive Surgical 145.76 Bn 141.37 Bn 1.83 Bn -
2 Becton Dickinson 41.48 Bn 40.47 Bn 2.15 Bn -
3 Medline 29.98 Bn 35.82 Bn 1.84 Bn -
4 Resmed 28.25 Bn 26.59 Bn 890.98 Mn 163.15 Mn
5 West Pharmaceutical Services 23.60 Bn 23.08 Bn 296.40 Mn 11.80 Mn
6 Solventum 13.72 Bn 13.72 Bn 1.10 Bn -
7 Cooper Companies 13.23 Bn 13.10 Bn 735.40 Mn 208.80 Mn
8 Align Technology 12.49 Bn 11.43 Bn 736.59 Mn -
9 Baxter International 10.74 Bn 8.69 Bn 891.00 Mn -
10 Pulse Biosciences 1.64 Bn 1.64 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2018 1.20 Mn
Sep 30, 2018 1.30 Mn
Jun 30, 2018 1.41 Mn
Mar 31, 2018 1.51 Mn
Dec 31, 2017 1.61 Mn
Sep 30, 2017 1.72 Mn
Jun 30, 2017 1.82 Mn